An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing

  1. Durán-Sotuela, A.
  2. Vázquez-García, J.
  3. Relaño-Fernández, S.
  4. Balboa-Barreiro, V.
  5. Fernández-Tajes, J.
  6. Blanco, F.J.
  7. Rego-Pérez, I.
Revista:
Frontiers in Pharmacology

ISSN: 1663-9812

Ano de publicación: 2024

Volume: 15

Tipo: Artigo

DOI: 10.3389/FPHAR.2024.1426826 GOOGLE SCHOLAR lock_openAcceso aberto editor